MHMartinho Campolina Rebello Horta

Martinho Campolina Rebello Horta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Martinho Campolina Rebello Horta has a total of 346 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Personalization of supportive orofacial care in the context of high-technology head and neck radiotherapy: a case report

    by Breno Amaral Rocha, Alyne Simões, Mayra Mendes Soares Teixeira, Angel da Silva Martinez, Carlos Antônio Lopes, Martinho Campolina Rebello Horta

    This case report describes the dental support provided to a patient undergoing radiotherapy for a malignant lip neoplasm, emphasizing the importance of tailoring orofacial care to specific patient needs. A 38-year-old male diagnosed with squamous cell carcinoma of the lip, presenting with anatomical and functional post-surgical sequelae, received dental care before, during, and after high-precision radiotherapy. Prophylactic and curative dental management was individualized, including a personalized intraoral device and photobiomodulation therapy. The patient achieved a favorable clinical outcome, maintaining oral hygiene and solid food intake throughout the treatment, with toxicities limited to grade 2 oral mucositis and grade 1 xerostomia. At the 9-month follow-up, there were no signs of tumor recurrence, xerostomia, or dysgeusia. Furthermore, the patient demonstrated improved mouth opening and no signs of radiation-induced caries. Within the limitations inherent to a case report, these findings suggest a potential role for personalized orofacial care in minimizing orofacial complications in the context of high-technology head and neck radiotherapy. Future studies with a higher level of evidence, such as randomized controlled clinical trials and systematic reviews are necessary to advance knowledge in this field.

  • Open Access

    Epidermoid Cyst of the Gingiva: A Rare Case Report and Literature Review

    by José Alcides Almeida de Arruda, Sicília Rezende Oliveira, Marcela Ferreira Abrahão Ribeiro, Martinho Campolina Rebello Horta, Giovanna Ribeiro Souto

    Oral epidermoid cysts are developmental lesions that account for less than 0.04% of all reported cases and typically occur in the floor of the mouth; gingival involvement is exceedingly rare. This report describes a 23‐year‐old female presenting with an asymptomatic, whitish papule on the attached gingiva near the right mandibular canine. Histopathologically, the lesion showed a cystic cavity mainly lined by orthokeratinized stratified squamous epithelium containing lamellar keratin, without cutaneous adnexal structures in the fibrous connective tissue capsule. No recurrence was observed after 15 months of follow‐up. A literature review identified eight epidermoid cysts involving the gingiva or alveolar ridge. This report underscores the importance of including this entity in the differential diagnosis of gingival papules and indicates that accurate clinical recognition coupled with histopathological confirmation ensures curative surgical outcomes.

  • Open Access

    Allergic contact stomatitis associated with toothpaste use in Brazil: a multicenter retrospective case series

    by Breno Amaral Rocha, Guilherme Veloso Ramos, Lilian de Barros, Giovanna Ribeiro Souto, Soraya de Mattos Camargo Grossmann, Paulo Eduardo Alencar Souza, Rodrigo Villamarim Soares, Alan Roger Santos-Silva, Marcio Ajudarte Lopes, Thaís Cristina Esteves-Pereira, et al.

    Objective: This study describes the clinical features and outcomes of Brazilian patients diagnosed with suspected allergic contact stomatitis (ACS) after using a newly introduced commercial toothpaste formulation. Methods: This multicenter retrospective case series included six patients evaluated between January and May 2025 by Oral Medicine services at four universities. Inclusion criteria comprised clinical signs and/or symptoms compatible with ACS, recent use of a new Colgate-Palmolive toothpaste formulation containing stannous fluoride, and no reported exposure to other allergens. Clinical data retrieved from patient records underwent descriptive analysis. Results: All patients presented acute oral symptoms including burning, pain, dysphagia, and dyslalia. Clinical signs included erythematous macules, white plaques, desquamation, vesicles, erosions and ulcers affecting different oral sites. Lesions resolved within 4 to 29 days after toothpaste discontinuation, with or without pharmacologic intervention. No cases required biopsy or patch testing. In all cases, the temporal relationship and remission following toothpaste withdrawal supported the diagnosis of ACS. Conclusions: This study highlights a potential association between toothpaste formulations and ACS. Given the complexity of toothpaste formulations and the absence of allergological testing, the causative substance remains uncertain. Clinicians should consider ACS in patients presenting with unexplained oral lesions and recent changes in oral hygiene products.

  • Odontogenic Tumors in South America ‐ A Multicenter Study of 4399 Cases From 20 Oral Pathology Centers

    by Lauren Frenzel Schuch, Alini Cardoso Soares, Elismauro Francisco de Mendonça, Victor Hugo Lopes de Oliveira Moreira, Diego Antonio Costa Arantes, Katman Bear Toledo Sanchez, Wilson Delgado Azañero, Ana Cristina Tetzner, Marina Rocha Fonseca Souza, Maria Carmen Pereira, et al.

    Objective: To describe the occurrence and clinicopathological features of odontogenic tumors (OTs) in a multicenter South American study. Methods: This retrospective study reviewed 207,434 biopsies across 20 oral pathology centers in 10 South American countries. All cases were included according to the 2022 World Health Organization (WHO) criteria. Data were analyzed descriptively. Results: A total of 4399 OTs were identified, representing 2.1% of all biopsies assessed in these centers. Most were benign (99.1%), mainly odontoma (38.5%) and ameloblastoma (34%). Malignant tumors were rare (0.9%). Patients had a mean age of 27.8 years, with peak incidence in the second decade, and a slight female predominance (male‐to‐female ratio 1:1.1). Most lesions were asymptomatic (87.8%), intraosseous (97.3%), and located in the mandible (62.5%), especially the posterior region. Radiographically, radiolucent lesions (49.9%) predominated. Tooth displacement (83.3%) and root resorption (82.8%) were frequently reported. Among cases with available data, surgical excision (41.2%) and enucleation (37.3%) were the most common treatments, and recurrence was observed in 20.1%. Conclusions: This multicenter study provides the largest dataset on OTs in South America. The results confirm the predominance of benign lesions and highlight the importance of collaborative studies, offering a basis for future clinical and research initiatives.


  • Oral Lesions in a Patient With Hodgkin's Lymphoma

    by Breno Amaral Rocha, Gianne Donato Costa Veloso, Christine Mendes Silveira, Polianne Alves Mendes, Giovanna Ribeiro Souto, Soraya de Mattos Camargo Grossmann, Paulo Eduardo Alencar Souza, Martinho Campolina Rebello Horta

  • Open Access

    Oropouche fever: An emerging arbovirus disease from the Americas with possible oral manifestations

    by Breno Amaral Rocha, Giovanna Ribeiro Souto, Soraya de Mattos Camargo Grossmann, Paulo Eduardo Alencar Souza, Rodrigo Villamarim Soares, Martinho Campolina Rebello Horta

    Oropouche fever (OROV fever) is an emerging arbovirus disease caused by Oropouche virus (OROV). The virus was reported to have a limited circulation in Central and South America, but there is a real possibility of international spread in the near future. Considering the current outbreak of OROV fever in the Americas, the Pan American Health Organization/World Health Organization has already published one Epidemiological Alert and two Epidemiological Updates in 2024. From January to early October 2024, 10,275 cases were confirmed in nine American countries, including imported cases in the United States and Canada. Moreover, 30 imported cases were reported for the first time in three European countries. Knowledge about OROV fever is still limited. Like common arbovirus diseases, the main clinical manifestations include fever, headache, arthralgia, myalgia, bleeding and rash. Gingival bleeding has been reported, and oral mucosal lesions may be another possible manifestation. The disease is usually mild and self-limiting, but severe complications, death and vertical transmission can occur. This article reviews OROV fever, addressing possible oral manifestations as well as the potential contribution of the dental community to prompt diagnosis and management.


  • Open Access

    Immunohistochemical expression of p53, ki-67, tenascin, and fibronectin in giant cell fibroma and traumatic fibroma of the oral mucosa

    by Ingrid Gomes de Oliveira, Adriana Aparecida Silva da Costa, Daniela Pereira Meirelles, Thalita Soares Tavares, João De Jesus Viana Pinheiro, Ricardo Alves de Mesquita, Martinho Campolina Rebello Horta, Patrícia Carlos Caldeira

    Objective: This study aimed to compare the immunoexpression of p53, ki-67, tenascin, and fibronectin between giant cell fibroma (GCF) and traumatic fibroma (TF), in order to explore a benign neoplastic or a reactive nature of GCF. Methods: A cross-sectional study was conducted. Samples of GCF and TF were retrieved from the files of Oral Pathology Service, matched by site and size. Immunohistochemistry for p53, ki-67, tenascin, and fibronectin was evaluated in the superficial and deep regions of the lesions using the Image J Software. The number of positive cells was determined for p53 and ki-67, and the positive area was established for tenascin and fibronectin. Statistical analysis was performed with Mann-Whitney and independent t-tests (p≤0.05). Results: Comparing to TF, GCF showed higher expression of p53 protein in superficial (p=0.009) and deep regions (p=0.027), as well as higher tenascin expression in deep regions (p=0.000). Ki-67 and fibronectin immunoexpression did not differ between GCF and TF (p>0.05). Conclusions: The results of the present study seem supportive of a benign neoplastic nature of GCF, rather than a reactive one, especially considering the p53 and tenascin expression. Further studies with larger samples and broader markers should confirm this hypothesis.

  • Descompressão de cisto radicular associado à cirurgia paraendodôntica: Relato de caso

    by Leandro Oliveira, Mariana Silveira Souza, Paulo Eduardo Alencar Souza, Martinho Campolina Rebello Horta

    O cisto radicular é um cisto de origem odontogénica causado por um processo inflamatório associado a dentes com diagnóstico de necrose pul...


  • Increased incidence of oral squamous cell carcinoma in Minas Gerais (Brazil): A study of 46 years

    by Laura Cascão Lopes, Mariela Dutra Gontijo de Moura, Martinho Campolina Rebello Horta, Giovanna Ribeiro Souto, Paulo Eduardo Alencar de Souza, Rodrigo Villamarim Soares, Soraya de Mattos Camargo Grossmann

  • Microvascular density analysis and histological parameters of oral cancer progression

    by Elis Angela Batistella, Andressa Fernanda Paza Miguel, Nicole Lonni Nascimento, Martinho Campolina Rebello Horta, Daniella Serafin Couto Vieira, Elena Riet Correa Rivero

    Objectives: This study aimed to investigate the role of blood and lymphatic microvascular density in the progression of oral squamous cell carcinoma (OSCC).Materials and Methods: The sample was composed of 54 cases of OSCC. The immunoexpression to anti‐alpha‐smooth muscle actin (α‐SMA) and to anti‐endoglin (CD105) was used to determine the microvessel density (MVD); anti‐podoplanin (D2‐40) was used to assess the lymphatic vessel density (LVD); vascular endothelial growth factor (VEGF) was evaluated in malignant cells. The histological differentiation, the worst pattern of invasion (WPOI), tumour thickness and tumour budding (TB) intensity were assessed using haematoxylin–eosin and anti‐pan‐cytokeratin (AE1/AE3). Patients' age and sex, TNM classification and follow‐up time were collected from the medical records.Results: MVD markers presented a similar pattern of expression in blood vessels. However, only α‐SMA + MVD was significantly higher among women and in tumours ≤4 cm. LVD was lower in tumours with lymph node metastasis. Regarding the histological parameters, high TB intensity was associated with histological differentiation, advanced clinical stage, greater tumour thickness and reduced disease‐free survival. No difference was found in VEGF.Conclusions: The decrease in OSCC LVD could be related to pathological node involvement, whereas high TB intensity could indicate OSCC progression and worse patient outcomes.